Alaunos Therapeutics Ownership | Who Owns Alaunos Therapeutics?


OverviewForecastRevenueFinancialsChart

Alaunos Therapeutics Ownership Summary


Alaunos Therapeutics is owned by 1.32% institutional investors, 7.09% insiders, and 91.59% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 1.33% of TCRT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.56% of its assets in Alaunos Therapeutics shares.

TCRT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAlaunos Therapeutics1.32%7.09%91.59%
SectorHealthcare Stocks 488.30%11.08%-399.38%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de21.35K1.33%$103.56K
Cibc private wealth group300.000.02%$1.46K
Group one trading300.000.02%$1.46M
Ronald blue trust135.000.01%$325.00
Raymond james financial99.000.01%$480.00
Federation des caisses desjardins du quebec86.000.01%$417.00K
Bokf, na66.000.00%$320.00
Key financial24.000.00%$116.00
Signaturefd23.000.00%$55.00
Advisornet financial19.000.00%$46.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Thurston, springer, miller, herd & titak---
Federation des caisses desjardins du quebec86.00-$417.00K
Eversource wealth advisors---
Truvestments capital1.00-$5.00
Tidemark---
Key financial24.00-$116.00
Advisornet financial19.00-$46.00
Sunbelt securities10.00-$19.00
Cibc private wealth group300.00-$1.46K
Ronald blue trust135.00-$325.00

Top Buyers

HolderShares% AssetsChange
Ronald blue trust135.00-135.00
Raymond james financial99.00-99.00
Key financial24.00-24.00
Federation des caisses desjardins du quebec86.00--
Truvestments capital1.00--

Top Sellers

HolderShares% AssetsChange
Eversource wealth advisors---40.00
Thurston, springer, miller, herd & titak---21.00
West paces advisors---10.00
Psi advisors---6.00
Tidemark---2.00

New Positions

HolderShares% AssetsChangeValue
Ronald blue trust135.00-135.00$325.00
Raymond james financial99.00-99.00$480.00
Key financial24.00-24.00$116.00

Sold Out

HolderChange
Tidemark-2.00
Psi advisors-6.00
West paces advisors-10.00
Thurston, springer, miller, herd & titak-21.00
Eversource wealth advisors-40.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20256-76.92%21,065-70.09%16.80%1-83.33%--100.00%
Mar 31, 202526-10.34%70,434-2.20%421.75%6-25.00%5-58.33%
Dec 31, 2024293.57%72,017-62.50%43.13%860.00%12-47.83%
Sep 30, 202428-40.43%192,061-92.10%115.21%5-61.54%23109.09%
Jun 30, 202447-2,430,2983.47%157.05%1344.44%11-69.44%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF24.91K1.56%-15.49K
Vanguard Total Stock Mkt Idx Inv17.35K1.08%-7.03K
Vanguard Institutional Extnd Mkt Idx Tr14.06K0.71%-6.41K
Fidelity Extended Market Index9.14K0.41%-64.00
BlackRock Extended Equity Market K2.98K0.19%-2.00
Extended Equity Market Fund K2.89K0.18%-58.00
Fidelity Series Total Market Index2.47K0.11%-1.57K
Fidelity Total Market Index2.38K0.11%-
NT Ext Equity Mkt Idx Fd - L1.36K0.08%-
Northern Trust Extended Eq Market Idx1.36K0.08%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 24, 2025Vieser Jaime-Buy$1.12K
Jun 24, 2025Postma Robert W-Buy$2.69K
Apr 11, 2025Postma Robert W-Buy$1.38K
Dec 31, 2024Vieser Jaime-Sell$4.39K
Dec 31, 2024Vieser Jaime-Sell$1.64K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q23-
2025 Q1--
2024 Q4-2
2024 Q3--

TCRT Ownership FAQ


Who Owns Alaunos Therapeutics?

Alaunos Therapeutics shareholders are primarily institutional investors at 1.32%, followed by 7.09% insiders and 91.59% retail investors. The average institutional ownership in Alaunos Therapeutics's industry, Biotech Stocks , is 307.10%, which Alaunos Therapeutics falls below.

Who owns the most shares of Alaunos Therapeutics?

Alaunos Therapeutics’s largest shareholders are Blackrock funding, inc. /de (21.35K shares, 1.33%), Cibc private wealth group (300 shares, 0.02%), and Group one trading (300 shares, 0.02%). Together, they hold 1.37% of Alaunos Therapeutics’s total shares outstanding.

Does Blackrock own Alaunos Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Alaunos Therapeutics.

Who is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested?

Thurston, springer, miller, herd & titak is Alaunos Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Alaunos Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of Alaunos Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Alaunos Therapeutics shares, with 1.56% of its total shares outstanding invested in 24.91K Alaunos Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools